Groupe Maisons De Famille
Climate Impact & Sustainability Data (2023)
Reporting Period: 2023
Environmental Metrics
Total Carbon Emissions:22,579 tCO2e/year (2023)
Total Energy Consumption:117,373 MWh/year (2023)
Water Consumption:909,268 m3/year (2023)
Waste Generated:181 tons/year (2023, excluding DOREAFAMILIE)
ESG Focus Areas
- Environmental Stewardship
- Social Responsibility
- Ethical Governance
Environmental Achievements
- Continued efforts to enhance carbon footprint assessment (scopes 1 & 2)
- Started a training program for management to facilitate decarbonization
- Insulated all pipes and singular points in boiler rooms (Maisons de Famille France)
- Started installing automated building management systems in three houses (Maisons de Famille France)
- Photovoltaics: Feasibility studies started (Maisons de Famille France)
- Raising awareness of eco-gestures among employees (La Villa)
- Launching of a photovoltaic panel installation project (Amavir)
- Installation of electric car chargers (Amavir)
- Achieved BREEAM certification for two new residences (Amavir)
- Implemented the use of tablets in resident rooms (Amavir)
- Adoption of new electric or hybrid company vehicles (Amavir)
- Introduced therapeutic vegetable gardens in facilities (Amavir)
- Scheduled transition to energy-efficient LED lighting (DOREAFAMILIE)
- Embarked on a solar panel trial project (DOREAFAMILIE)
- Negotiating with building owners to enhance insulation (DOREAFAMILIE)
- Planned improvements to heating and cooling facilities (DOREAFAMILIE)
- Sustainable Phone Usage: Renting mobile phones through Everphone, supporting a project in Soacha, Colombia (DOREAFAMILIE)
Social Achievements
- Development of a Quality and Human Resources policy
- Enhancement of quality dashboard
- Implementation of a common internal satisfaction survey tool (La Villa, Amavir, DOREAFAMILIE)
- Strengthening of seniority and turnover monitoring
Governance Achievements
- Strengthened compliance and major risk management framework
Climate Goals & Targets
Long-term Goals:
- Not disclosed
Medium-term Goals:
- Reduce energy consumption by 15% by 2030 (Maisons de Famille)
- Improve carbon footprint performance (Amavir)
Short-term Goals:
- Not disclosed
Environmental Challenges
- Shortage of healthcare personnel
- Escalating energy costs
- Restructuring of DOREAFAMILIE (Germany)
- Aging population and increase in dependency
- Increase in chronic diseases
- Accommodation capacity and home care challenges
- Environmental sustainability
- High turnover ratio in the care sector
Mitigation Strategies
- Investments in training and development programs to attract and retain top talent
- Exploring innovative care delivery models
- Restructuring of DOREAFAMILIE resulting in a streamlined and more efficient operation
- Expand network of facilities and services
- Invest in specialized programs and training for staff
- Continue digital transformation initiatives
- Implement health promotion programs and chronic disease management protocols
- Foster interdisciplinary collaboration and partnerships
- Utilize digital health solutions
- Diversify service offering
- Implement environmental initiatives within facilities
- Promote environmental awareness and education
- Collaborate with local communities and environmental organizations
- Implement targeted recruitment and retention strategies
- Offer competitive salary packages, professional development opportunities, and supportive work environments
- Implement innovative staffing models
Supply Chain Management
Responsible Procurement
- Regular audits of suppliers (all affiliates)
- Use of biodegradable cleaning materials (DOREAFAMILIE)
- Favoring local suppliers (Amavir and DOREAFAMILIE)
Climate-Related Risks & Opportunities
Physical Risks
- Extreme heat waves
- Natural disasters
Transition Risks
- Changing regulations on emissions and climate change
Opportunities
- Renewable energy usage (solar, thermal, and biomass)
Reporting Standards
Frameworks Used: GRI, SASB, Global Compact, Sustainable Development Goals
Certifications: ISO 14001 (Amavir), BREEAM (Amavir)